36.6 F
New York
Wednesday, January 27, 2021

Pfizer [NYSE: PFE], BioNTech [NASDAQ: BNTX] Soars After Receiving Fast Track Designation From FDA

Must read

JPMorgan [NYSE: JPM] Announced To Initiate A Digital Retail Bank In The United Kingdom

JPMorgan Chase revealed that the company will launch a new digital retail bank in the United Kingdom offering the customer of the region...

Humanigen [NASDAQ: HGEN] Announces Expansion Of Manufacturing Agreement With Ajinomoto Bio-Pharma

Humanigen Inc revealed that the company has extended the manufacturing agreement with  Ajinomoto BioPharma to support the fill-finish of Lenzilumab. The Lenzilumab is...

Synchrony [NYSE: SYF] Announced To Purchase Allegro Credit

Synchrony Financials revealed that the company entered into a definitive contract to Purchase Allegro Credit. Allegro Credit's customer base and merchant network will...

Vericel Corp [NASDAQ: VCEL] Names Joe Mara As The New CFO

Vericel Corporation revealed that the company has named Joe Mara as the CFO of the company. He has over more than 20 years...

Pfizer, Inc. [NYSE: PFE] and BioNTech SE [NASDAQ: BNTX] has got a ‘Fast Track’ designation from US Food and Drug Administration (FDA) for their two COVID-19 vaccine candidate, the companies announced today. Both companies continuously striving to develop a coronavirus vaccine.

The BNT162b1 and BNT162b2 are two highly developed vaccine candidates in the BNT162 program that are currently being tested in Phase 1/2 clinical studies in the United States and Germany. The ‘Fast Track’ designation was granted to the companies based on the preliminary data from phase 1/2 data.

The fast-track label allows for a more fast development process between companies and regulatory agencies and enables drug manufacturers to gain faster approval with the rolling review process of the data presented.

Pfizer and BioNTech disclosed the data of Phase 1/2 study for the product candidate BNT162b1 on July 1, 2020. The chief medical officer at BioNTech Özlem Türeci said that the company is looking forward to work with the FDA and its partner Pfizer for the development of the coronavirus vaccine.

After receiving ‘Fast Track’ label the shares of Pfizer and BioNTech both jumped and closed green. Pfizer shares soared 3.49% during the trading of Monday. PFE has a day low and high range of $34.53-$35.05, respectively. This company had a trading volume of roughly 8.12 million as compared to the average volume of 27.89 million.

In the past 52-weeks of trading, this company has fluctuated from a low of $27.88 and a high of 43.56. Its return on assets, investment, and equity is $9.60%, 14.70%, and 25.00%, respectively.

On the other hand, BioNTech SE shares climbed 10.33% at $77.63 during the trading of Monday. This company has a total market capitalization of 15.00 billion. It has moved up 519.80% from its 52-weeks low and moved down -26.07% from 52-weeks high.

BNTX has a gross margin of 88.30% and returns on investment (ROI) is -31.40%. Meanwhile, if we look at its liquidity, BNTX showed the current ratio of 3.70 and the quick ratio is also the same.

More articles

Latest article

A Paychex [NASDAQ: PAYX] Subsidiary Announces Strategic Collaboration With Zoho Books

SurePayroll, a subsidiary of Paychex company revealed that the company has formed a collaboration with Zoho books. SurePAyroll is a provider of small...

MGP Ingredients [NASDAQ: MGPI] Announced To Acquire Luxco and Its Affiliate Companies

MGP Ingredients  revealed a definitive contract to purchase Luxco, Inc and its affiliated companies. Luxco is an alcohol beverage company with more than 60...

Conformis [NASDAQ: CFMS] Entered A Non-Exclusive agreement with SITES Medical

Conformis Inc revealed that the company inked a development and supply contract with sites medical. Both of the companies will work together to...

Colliers International [NASDAQ: CIGI] Announces Executive Leadership Changes For Australian Business

Colliers International  reported that the company has named Malcom Tyson as the new Chief Executive Officer. He is appointed as the CEO so...

Korn Ferry [NYSE: KFY] Announces Expansion Of Its Footprint In Russian Market

Korn Fery revealed that the company is expanding its footprint in Russia. Moreover, it is adding a high expertise team of executive search...

Haemonetics [NYSE: HAE] To Purchase Cardiva For An Upfront Payment Of $475M

Haemonetics Corporation revealed that the company has inked a definitive contract to purchase Cardiva Medical Inc. Under the contract, Haemontics will pay an...

Philips [NYSE: PHG] To Purchase Capsule Technologies For Cash Consideration Of USD 635M

Koninklijke Philip revealed that the company has inked a contract to purchase Capsule technologies. The company will pay a cash price of $636...

Thermo Fisher Scientific [NYSE: TMO] To Purchase Mesa Biotech For Approx. $450M In Cash

Thermo fisher scientific inc revealed that the company has signed a definitive contract to purchase Mesa Biotech. Thermo will pay a value price...